Frank Eduard, Park Sooyoung, Harrer Elias, Flügel Jana L, Fischer Marcel, Nuernberger Patrick, Rehbein Julia, Breder Alexander
Institute for Organic Chemistry, University of Regensburg, 93053 Regensburg, Germany.
Institute for Physical and Theoretical Chemistry, University of Regensburg, 93053 Regensburg, Germany.
J Am Chem Soc. 2024 Dec 18;146(50):34383-34393. doi: 10.1021/jacs.4c09405. Epub 2024 Dec 7.
Diarylmethanes play, in part, a pivotal role in the design of highly potent, chiral, nonracemic drugs whose bioactivity is typically affected by the substitution pattern of their arene units. In this context, certain arenes such as -substituted benzenes or unsubstituted heteroarenes cause particular synthetic challenges, since such isosteric residues at the central methane carbon atom are typically indistinguishable for a chiral catalyst. Hence, the stereoselective incorporation of isosteric (hetero)arenes into chiral methane scaffolds requires the use of stoichiometrically differentiated building blocks, which is typically realized through preceding redox-modifying operations such as metalation or halogenation and thus associated with disadvantageous step- and redox-economic traits. As a counter-design, we report herein a generalized enantioselective synthesis of chiral diarylmethanes by means of an asymmetric migratory Tsuji-Wacker oxidation of simple stilbenes. The title protocol relies on the well-adjusted interplay of aerobic photoredox and selenium-π-acid catalysis to allow for the installation of a broad variety of arenes, including isosteric ones, into the methane core. Facial differentiation and regioselectivity are solely controlled by the selenium catalyst, which (a) renders the /-configuration of the stilbene substrates inconsequential and (b) permits the stereodivergent synthesis of both product enantiomers from a single catalyst enantiomer, simply by employing constitutionally isomeric starting materials. Altogether, this multicatalytic platform offers the target structures with high levels of enantioselectivity in up to 97% , which has also been successfully exploited in expedited syntheses of antihistaminic ()- and ()-neobenodine.
二芳基甲烷在设计高效、手性、非外消旋药物中发挥着关键作用,这些药物的生物活性通常受其芳烃单元取代模式的影响。在此背景下,某些芳烃,如对位取代的苯或未取代的杂芳烃,会带来特殊的合成挑战,因为中心甲烷碳原子上的此类等电子残基对手性催化剂而言通常难以区分。因此,将等电子(杂)芳烃立体选择性地引入手性甲烷骨架需要使用化学计量有差异的构建块,这通常通过诸如金属化或卤化等先前的氧化还原修饰操作来实现,因而具有不利的步骤经济性和氧化还原经济性。作为一种反向设计,我们在此报告通过简单芪的不对称迁移式Tsuji-Wacker氧化对映选择性合成手性二芳基甲烷的通用方法。本方法依赖于有氧光氧化还原与硒-π酸催化的良好协同作用,以便将包括等电子芳烃在内的多种芳烃引入甲烷核心。面部分化和区域选择性仅由硒催化剂控制,该催化剂(a)使芪底物的E/Z构型无关紧要,且(b)仅通过使用结构异构体起始原料,就能从单一催化剂对映体立体发散地合成两种产物对映体。总之,这个多催化平台能以高达97%的对映选择性提供目标结构,这也已成功应用于抗组胺药(+)-和(-)-新贝诺定的快速合成中。